Skip to main content

Peer Review reports

From: Landscape of clinical drug development of ADCs used for the pharmacotherapy of cancers: an overview of clinical trial registry data from 2002 to 2022

Original Submission
12 Jan 2024 Submitted Original manuscript
28 Feb 2024 Reviewed Reviewer Report
3 May 2024 Reviewed Reviewer Report
15 May 2024 Author responded Author comments - Wenjing Zhou
Resubmission - Version 2
15 May 2024 Submitted Manuscript version 2
17 May 2024 Author responded Author comments - Wenjing Zhou
Resubmission - Version 3
17 May 2024 Submitted Manuscript version 3
6 Jun 2024 Reviewed Reviewer Report
19 Jun 2024 Author responded Author comments - Wenjing Zhou
Resubmission - Version 4
19 Jun 2024 Submitted Manuscript version 4
3 Jul 2024 Reviewed Reviewer Report
16 Jul 2024 Author responded Author comments - Wenjing Zhou
Resubmission - Version 5
16 Jul 2024 Submitted Manuscript version 5
Publishing
17 Jul 2024 Editorially accepted
26 Jul 2024 Article published 10.1186/s12885-024-12652-5

You can find further information about peer review here.

Back to article page